Extreme Networks, Inc. (EXTR)

Verve Therapeutics Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	1,140	1,117	1,312	1,112	1,009
Revenue Growth (YoY)	2.05%	-14.88%	17.99%	10.19%	6.48%
Cost of Revenue	430.94	486.37	557.73	482.38	424.3
Gross Profit	709.13	630.83	754.72	629.94	585.12
Selling, General & Admin	467.18	445.74	426.84	363.17	343.04
Research & Development	221.46	211.93	214.27	190.59	197
Operating Expenses	690.69	659.71	643.16	556.99	546.15
Operating Income	18.44	-28.88	111.56	72.95	38.98
Interest Expense	-15.93	-16.99	-17.39	-12.79	-22.86
Interest & Investment Income	4.31	4.56	3.16	0.41	0.35
Currency Exchange Gain (Loss)	-	0.6	0.8	1.7	-2.2
Other Non Operating Income (Expenses)	-0.98	-0.47	-0.78	-1.32	0.51
EBT Excluding Unusual Items	5.84	-41.18	97.36	60.95	14.79
Merger & Restructuring Charges	-1.49	-36.32	-3.25	-8.76	-4.6
Other Unusual Items	-0.08	-	-	-	-
Pretax Income	4.27	-77.5	94.11	52.19	10.19
Income Tax Expense	11.74	8.47	16.03	7.92	8.25
Net Income	-7.47	-85.96	78.07	44.27	1.94
Net Income to Common	-7.47	-85.96	78.07	44.27	1.94
Net Income Growth	-	-	76.35%	2186.72%	-
Shares Outstanding (Basic)	132	129	129	129	124
Shares Outstanding (Diluted)	132	129	134	133	128
Shares Change (YoY)	2.35%	-3.26%	0.12%	4.56%	6.56%
EPS (Basic)	-0.06	-0.66	0.60	0.34	0.02
EPS (Diluted)	-0.06	-0.66	0.58	0.33	0.02
EPS Growth	-	-	75.76%	2014.03%	-
Free Cash Flow	127.32	37.37	235.41	112.74	127.36
Free Cash Flow Per Share	0.96	0.29	1.76	0.84	1.00
Gross Margin	62.20%	56.46%	57.50%	56.63%	57.97%
Operating Margin	1.62%	-2.58%	8.50%	6.56%	3.86%
Profit Margin	-0.66%	-7.70%	5.95%	3.98%	0.19%
Free Cash Flow Margin	11.17%	3.35%	17.94%	10.14%	12.62%
EBITDA	37.66	-5.33	146.44	113.11	94.29
EBITDA Margin	3.30%	-0.48%	11.16%	10.17%	9.34%
D&A For EBITDA	19.22	23.55	34.88	40.16	55.32
EBIT	18.44	-28.88	111.56	72.95	38.98
EBIT Margin	1.62%	-2.58%	8.50%	6.56%	3.86%
Effective Tax Rate	274.75%	-	17.04%	15.18%	80.99%
Revenue as Reported	1,140	1,117	1,312	1,112	1,009

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q